Allogene Therapeutics
Debbie W. is a seasoned financial professional with extensive experience in accounts payable and administrative roles across various organizations. Currently serving as a Senior Accounts Payable Accountant at Allogene Therapeutics since January 2019, Debbie has previously worked as Accounts Payable Specialist II at Cytokinetics and held multiple positions including Office Manager at the Pacifica Chamber of Commerce and Data Specialist at DocketMasters. Early career experiences include roles in the South San Francisco Unified School District as a Senior Office Specialist and School Support Secretary, alongside serving as a Teachers Assistant. Debbie possesses strong organizational and communication skills, demonstrating a commitment to efficiency and attention to detail throughout a diverse professional background.
This person is not in the org chart
Allogene Therapeutics
1 followers
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.